Wells Fargo’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $177K | Sell |
15,865
-9,485
| -37% | -$106K | ﹤0.01% | 4452 |
|
|
2025
Q1 | $312K | Buy |
25,350
+18,867
| +291% | +$232K | ﹤0.01% | 3969 |
|
|
2024
Q4 | $72.5K | Buy |
6,483
+2,279
| +54% | +$25.5K | ﹤0.01% | 4865 |
|
|
2024
Q3 | $29.3K | Sell |
4,204
-2,166
| -34% | -$15.1K | ﹤0.01% | 5129 |
|
|
2024
Q2 | $48.2K | Buy |
6,370
+4,288
| +206% | +$32.4K | ﹤0.01% | 4945 |
|
|
2024
Q1 | $27.5K | Buy |
2,082
+2,001
| +2,470% | +$26.4K | ﹤0.01% | 5092 |
|
|
2023
Q4 | $835 | Buy |
81
+7
| +9% | +$72 | ﹤0.01% | 5826 |
|
|
2023
Q3 | $720 | Sell |
74
-149
| -67% | -$1.45K | ﹤0.01% | 5901 |
|
|
2023
Q2 | $1K | Buy |
223
+4
| +2% | +$18 | ﹤0.01% | 6012 |
|
|
2023
Q1 | $1.02K | Buy |
219
+151
| +222% | +$701 | ﹤0.01% | 6049 |
|
|
2022
Q4 | $101 | Sell |
68
-18
| -21% | -$27 | ﹤0.01% | 6463 |
|
|
2022
Q3 | $0 | Buy |
86
+43
| +100% | – | ﹤0.01% | 6799 |
|
|
2022
Q2 | $0 | Sell |
43
-1,553
| -97% | – | ﹤0.01% | 6950 |
|
|
2022
Q1 | $13K | Sell |
1,596
-2,475
| -61% | -$20.2K | ﹤0.01% | 5826 |
|
|
2021
Q4 | $41K | Sell |
4,071
-6,108
| -60% | -$61.5K | ﹤0.01% | 5593 |
|
|
2021
Q3 | $161K | Sell |
10,179
-42
| -0.4% | -$664 | ﹤0.01% | 4909 |
|
|
2021
Q2 | $243K | Buy |
+10,221
| New | +$243K | ﹤0.01% | 4655 |
|